Beta Bionics (BBNX)

Profile

Full Name

Beta Bionics, Inc.

Ticker Symbol

BBNX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

January 30, 2025

Indexes

Not included

Website

http://www.betabionics.com

Employees

291

Key Details

Price

$10.77

Market Cap

$414.56M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$65.12M(+442.93% YoY)

Annual EPS

-

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.77
BBNX price is $10.77

Price All-time High

$23.81
BBNX price is currently -54.77% below its historical high of $23.81

Price Most Recent Change

-10.62%
BBNX price was down -10.62% on Apr 3, 2025

Price YTD Change

-
BBNX price ytd change is unknown

Price 1-year Change

-
BBNX price 1-year change is unknown

Price 3-year Change

-
BBNX price 3-year change is unknown

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$414.56M
BBNX market capitalization is $414.56 million

Market Cap 3-year Change

-
BBNX market capitalization 3-year change is unknown

Market Cap All-time High

$916.50M
BBNX market capitalization is currently -54.77% below its historical high of $916.50 million

Market Cap Sector Rank

67.76%
BBNX market capitalization is higher than 67.76% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
BBNX shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
BBNX shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.03
BBNX beta is 2.03

200-day SMA

$18.16
BBNX price is currently -40.69% below its 200-day simple moving average

50-day SMA

$18.16
BBNX price is currently -40.69% below its 50-day simple moving average

RSI

26.74
BBNX 14-day relative strength index is 26.74

Volume

1.39
BBNX 30-day relative volume is 1.39

ATR

$1.32
BBNX average true range is $1.32

10-day Historical Volatility

107.11%
BBNX 10-day historical volatility is 107.11%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$65.12M
BBNX annual revenue is $65.12 million

Revenue Analysts Estimate

$82.68M
BBNX annual revenue is currently -21.23% lower than the consensus analysts' forecast

Revenue 1-year Change

+442.93%
BBNX annual revenue is up +442.93% year-on-year

Revenue Sector Rank

-
BBNX annual revenue is unknown

EPS

EPS

-
BBNX annual earnings per share value is unknown

EPS Analysts Estimate

-$1.73
BBNX annual earnings per share is currently equal to the consensus analysts' forecast

EPS 1-year Change

-
BBNX annual earnings per share 1-year change is unknown

EPS Sector Rank

-
BBNX annual earnings per share is unknown

Profit

Gross Profit

$35.89M
BBNX annual gross profit is $35.89 million

Gross Margin

55.11%
BBNX annual gross profit margin is 55.11%

Operating Profit

-$45.25M
BBNX annual operating income is -$45.25 million

Operating Margin

-69.48%
BBNX annual operating profit margin is -69.48%

Net Income

-$54.76M
BBNX annual net profit is -$54.76 million

Net Margin

-
BBNX annual net profit margin value is unknown

Expenses

Total Expenses

$110.38M
BBNX annual total expenses is $110.38 million

Operating Expenses

$81.14M
BBNX annual total operating expenses is $81.14 million

Cost Of Goods Sold

$29.24M
BBNX annual cost of goods sold is $29.24 million

Selling, General & Administrative Expenses

$54.95M
BBNX annual SGA is $54.95 million

Depreciation And Amortization

$2.28M
BBNX annual depreciation & amortization is $2.28 million

Interest Expense

-
BBNX annual interest expense value is unknown

Income Tax

-
BBNX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$45.25M
BBNX annual earnings before interest & taxes is -$45.25 million

EBITDA

-$29.56M
BBNX annual EBITDA is -$29.56 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$149.65M
BBNX annual total assets is $149.65 million

Non Current Assets

$16.72M
BBNX annual long term assets is $16.72 million

Current Assets

$132.92M
BBNX annual total current assets is $132.92 million

Cash And Cash Equivalents

$30.43M
BBNX annual cash & cash equivalents is $30.43 million

Accounts Receivable

$12.00M
BBNX annual accounts receivable is $12.00 million

Inventory

$13.32M
BBNX annual inventory is $13.32 million

Liabilities

Total Liabilities

$395.00M
BBNX annual total liabilities is $395.00 million

Long Term Liabilities

$373.86M
BBNX annual total long term liabilities is $373.86 million

Current Liabilities

$21.15M
BBNX annual total current liabilities is $21.15 million

Accounts Payable

$2.85M
BBNX annual accounts payable is $2.85 million

Debt

Total Debt

$7.25M
BBNX annual total debt is $7.25 million

Total Debt 1-year Change

+71.8%
BBNX annual total debt is up +71.8% year-on-year

Long Term Debt

$5.73M
BBNX annual long term debt is $5.73 million

Short Term Debt

-
BBNX annual short term debt value is unknown

Equity & Capital

Shareholders Equity

-$245.36M
BBNX annual stockholders equity is -$245.36 million

Book Value

-$245.36M
BBNX annual book value is -$245.36 million

Retained Earnings

-$296.74M
BBNX annual retained earnings is -$296.74 million

Working Capital

$111.78M
BBNX annual working capital is $111.78 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$48.27M
BBNX annual cash flow from operations is -$48.27 million

Cash From Operations 1-year Change

-48.78%
BBNX annual cash flow from operations is down -48.78% year-on-year

Cash From Investing

-$3.48M
BBNX annual cash flow from investing activities is -$3.48 million

Cash From Investing 1-year Change

+95.01%
BBNX annual cash flow from investing activities is up +95.01% year-on-year

Cash From Financing

$55.62M
BBNX annual cash flow from financing activities is $55.62 million

Cash From Financing 1-year Change

-44.95%
BBNX annual cash flow from financing activities is down -44.95% year-on-year

CAPEX

CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

CAPEX 1-year Change

+744.53%
BBNX annual capital expenditures is up +744.53% year-on-year

Free Cash Flow

Free Cash Flow

-$51.67M
BBNX annual free cash flow is -$51.67 million

Free Cash Flow 1-year Change

-57.3%
BBNX annual free cash flow is down -57.3% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

55.11%
BBNX annual gross profit margin is 55.11%

Operating Margin

-69.48%
BBNX annual operating profit margin is -69.48%

Net Margin

-
BBNX annual net profit margin value is unknown

ROA & ROE

ROA

-36.59%
BBNX annual return on assets is -36.59%

ROE

22.32%
BBNX annual return on equity is 22.32%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BBNX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BBNX price to earnings ratio is unknown

PB Ratio

PB Ratio

-1.69
BBNX price to book ratio is -1.69

PB Ratio Sector Rank

6.73%
BBNX price to book ratio is higher than 6.73% of companies in Healthcare sector

PS Ratio

PS Ratio

20.28
BBNX price to sales ratio is 20.28

PS Ratio Sector Rank

87.2%
BBNX price to sales ratio is higher than 87.2% of companies in Healthcare sector

Enterprise value

Enterprise Value

$391.38M
BBNX enterprise value is $391.38 million

Enterprise Value Sector Rank

66.61%
BBNX enterprise value is higher than 66.61% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-190.55
BBNX EV/EBITDA is -190.55

EV/EBITDA Sector Rank

0.7%
BBNX EV/EBITDA is higher than 0.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

6.29
BBNX annual current ratio is 6.29

Quick Ratio

5.66
BBNX annual quick ratio is 5.66

Leverage

Debt To Equity

-0.03
BBNX annual debt to equity ratio is -0.03

Interest Coverage Ratio

-
BBNX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
BBNX piotroski f-score value is unknown

Altman Z-Score

-1.81
BBNX altman z-score is -1.81

Analyst ratings

Recent major analysts updates

Feb 24, 25 Stifel
Buy
Feb 24, 25 Piper Sandler
Overweight
Feb 24, 25 Leerink Partners
Outperform
Feb 24, 25 Lake Street
Buy
Feb 20, 25 Ladenburg Thalmann
Buy
Feb 20, 25 Baird
Neutral

Institutional Ownership

Similar stocks

CAPR logo
Capricor Therapeutics (CAPR)
SAGE logo
Sage Therapeutics (SAGE)
TBPH logo
Theravance Biopharma (TBPH)
Enhabit (EHAB)
SNDA logo
Sonida Senior Living (SNDA)
TYRA logo
Tyra Biosciences (TYRA)
SRDX logo
Surmodics (SRDX)
MNMD logo
Mind Medicine (MindMed) (MNMD)
OMER logo
Omeros (OMER)
  • What is the ticker symbol for Beta Bionics?
  • Does Beta Bionics pay dividends?
  • What sector is Beta Bionics in?
  • What industry is Beta Bionics in?
  • What country is Beta Bionics based in?
  • When did Beta Bionics go public?
  • Is Beta Bionics in the S&P 500?
  • Is Beta Bionics in the NASDAQ 100?
  • Is Beta Bionics in the Dow Jones?
  • When was Beta Bionics's last earnings report?
  • When does Beta Bionics report earnings?
  • Should I buy Beta Bionics stock now?

What is the ticker symbol for Beta Bionics?

The ticker symbol for Beta Bionics is NASDAQ:BBNX

Does Beta Bionics pay dividends?

No, Beta Bionics does not pay dividends

What sector is Beta Bionics in?

Beta Bionics is in the Healthcare sector

What industry is Beta Bionics in?

Beta Bionics is in the Medical Devices industry

What country is Beta Bionics based in?

Beta Bionics is headquartered in United States

When did Beta Bionics go public?

Beta Bionics's initial public offering (IPO) was on January 30, 2025

Is Beta Bionics in the S&P 500?

No, Beta Bionics is not included in the S&P 500 index

Is Beta Bionics in the NASDAQ 100?

No, Beta Bionics is not included in the NASDAQ 100 index

Is Beta Bionics in the Dow Jones?

No, Beta Bionics is not included in the Dow Jones index

When was Beta Bionics's last earnings report?

Beta Bionics's most recent earnings report was on Mar 25, 2025

When does Beta Bionics report earnings?

The next expected earnings date for Beta Bionics is May 30, 2025

Should I buy Beta Bionics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page